Loading...

About Us

Zehza Life sciences, where innovation and expertise converge to advance pharmaceutical development.

Welcome to Zehza Life sciences, where innovation meets expertise in pharmaceutical development. Under the guidance of Dr. Moinuddin Syed, our skilled team of pharmaceutical scientists is committed to pushing the boundaries of research and development.

We specialize in advancing cutting-edge solutions across various therapeutic areas, ensuring progress and excellence in every project. Join us as we lead the way in transforming healthcare through science and innovation.

Meet Our Leader
Dr. Moinuddin Syed
Voice President

At Zehza Lifesciences, our strength lies in the expertise of our dedicated team, spearheaded by Dr. Moinuddin Syed. With a distinguished career spanning nearly two decades, Dr. Syed brings unparalleled scientific leadership and management experience to our organization.
Dr. Syed has garnered extensive experience with industry leaders such as IPCA Labs, GlaxoSmithKline, USV Ltd., and Wockhardt Ltd. His proven track record includes building and scaling R&D organizations to foster new product innovation and leading transformative initiatives to align organizations with strategic business goals.
Dr. Syed has transformed pharmaceutical R&D through strategic innovation and leadership. His work with major pharmaceutical companies has led to Enhanced R&D Capabilities, Building and scaling-up organizations to drive new product innovations. He Developed R&D strategies that align with business priorities and drive top-line growth.
Dr. Syed has Innovative Contributions of Over 10 patents and multiple research publications advancing the field of Drug Delivery and Formulation Development.

Our Team Experience

At the heart of our operations is a team of seasoned professionals specializing in the formulation development of drugs across diverse dosage forms, including NDDS, Modified Release (MR), and Immediate Release (IR) for markets in the US, Europe, and the Rest of the World (ROW). Our expertise spans solid, liquid, and parenteral dosage forms, with a strong track record in developing and scaling up products.
Our team meticulously manages the budget from initial development through to validation batches, ensuring efficient resource allocation and securing management approvals. We excel in the scale-up, manufacturing, and validation of Exhibit Batches, coordinating seamlessly across departments to drive project success.
With profound expertise in advanced formulations such as Modified Release tablets, Multi-Unit Particulate Systems, Powder for Solution, Chrono-Modified tablets, Liquid-Filled Hard Gelatin Capsules, and sustained-release suspensions based on Wurster technology, we tackle complex challenges with innovative solutions. Our commitment extends to risk assessment, mitigation strategies for existing products, and implementing Near-Infrared (NIR) based Process Analytical Technology (PAT) for enhanced project accuracy.
We guide plant-level investigations for Out of Specification (OOS) and Out of Trend (OOT) results, oversee third-party Contract Manufacturing Organizations (CMOs) for project transfers, and reformulate existing projects to meet evolving needs. Our expertise also includes responding to regulatory queries and establishing robust R&D and pilot scale plants.
Our team's comprehensive experience ensures that we deliver high-quality, compliant, and market-ready products efficiently and effectively.